-
Something wrong with this record ?
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network
Z. Vinarov, B. Abrahamsson, P. Artursson, H. Batchelor, P. Berben, A. Bernkop-Schnürch, J. Butler, J. Ceulemans, N. Davies, D. Dupont, GE. Flaten, N. Fotaki, BT. Griffin, V. Jannin, J. Keemink, F. Kesisoglou, M. Koziolek, M. Kuentz, A. Mackie,...
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
- MeSH
- Administration, Oral MeSH
- Gastrointestinal Tract metabolism MeSH
- Food-Drug Interactions MeSH
- Intestinal Absorption * MeSH
- Pharmaceutical Preparations chemistry metabolism MeSH
- Humans MeSH
- Computer Simulation MeSH
- Drug Compounding MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Although oral drug delivery is the preferred administration route and has been used for centuries, modern drug discovery and development pipelines challenge conventional formulation approaches and highlight the insufficient mechanistic understanding of processes critical to oral drug absorption. This review presents the opinion of UNGAP scientists on four key themes across the oral absorption landscape: (1) specific patient populations, (2) regional differences in the gastrointestinal tract, (3) advanced formulations and (4) food-drug interactions. The differences of oral absorption in pediatric and geriatric populations, the specific issues in colonic absorption, the formulation approaches for poorly water-soluble (small molecules) and poorly permeable (peptides, RNA etc.) drugs, as well as the vast realm of food effects, are some of the topics discussed in detail. The identified controversies and gaps in the current understanding of gastrointestinal absorption-related processes are used to create a roadmap for the future of oral drug absorption research.
Abbvie Deutschland GmbH and Co KG Ludwigshafen Germany
Advanced Drug Delivery Pharmaceutical Sciences R and D AstraZeneca Gothenburg Sweden
College of Pharmaceutical Sciences Ritsumeikan University Shiga Japan
Department of Chemical and Pharmaceutical Engineering Sofia University Sofia Bulgaria
Department of Pharmaceutical and Pharmacological Sciences KU Leuven Leuven Belgium
Department of Pharmacology and Toxicology Radboud University Medical Center Nijmegen the Netherlands
Department of Pharmacy and Pharmacology University of Bath Bath United Kingdom
Department of Pharmacy National and Kapodistrian University of Athens Athens Greece
Department of Pharmacy UiT The Arctic University of Norway Tromsø Norway
Department of Pharmacy University of Copenhagen Copenhagen Denmark
Department of Pharmacy Uppsala University Uppsala Sweden
Drug Product Design Pfizer PGRD Sandwich United Kingdom
F Hoffmann La Roche Ltd Basel Switzerland
Faculty of Medicine University of Medicine and Pharmacy of Iasi Romania
Faculty of Pharmacy Charles University Hradec Králové Czech Republic
GlaxoSmithKline Research and Development Ware United Kingdom
INRAE Institut Agro STLO Rennes France
Institute of Microbiology of the Czech Academy of Sciences Prague Czech Republic
Janssen Pharmaceutica NV Beerse Belgium
Lonza Pharma and Biotech Colmar France
Monash Institute of Pharmaceutical Sciences Monash University Parkville Australia
Pharmaceutical Development UCB Pharma SA Braine l'Alleud Belgium
Pharmaceutical Sciences Merck and Co Inc Rahway NJ USA
Physiolution Polska Sp Z o o Wroclaw Poland
School of Food Science and Nutrition University of Leeds Leeds United Kingdom
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004472
- 003
- CZ-PrNML
- 005
- 20220127145219.0
- 007
- ta
- 008
- 220113s2021 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.addr.2021.02.001 $2 doi
- 035 __
- $a (PubMed)33610694
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Vinarov, Zahari $u Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; Department of Chemical and Pharmaceutical Engineering, Sofia University, Sofia, Bulgaria
- 245 10
- $a Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network / $c Z. Vinarov, B. Abrahamsson, P. Artursson, H. Batchelor, P. Berben, A. Bernkop-Schnürch, J. Butler, J. Ceulemans, N. Davies, D. Dupont, GE. Flaten, N. Fotaki, BT. Griffin, V. Jannin, J. Keemink, F. Kesisoglou, M. Koziolek, M. Kuentz, A. Mackie, AJ. Meléndez-Martínez, M. McAllister, A. Müllertz, CM. O'Driscoll, N. Parrott, J. Paszkowska, P. Pavek, CJH. Porter, C. Reppas, C. Stillhart, K. Sugano, E. Toader, K. Valentová, M. Vertzoni, SN. De Wildt, CG. Wilson, P. Augustijns
- 520 9_
- $a Although oral drug delivery is the preferred administration route and has been used for centuries, modern drug discovery and development pipelines challenge conventional formulation approaches and highlight the insufficient mechanistic understanding of processes critical to oral drug absorption. This review presents the opinion of UNGAP scientists on four key themes across the oral absorption landscape: (1) specific patient populations, (2) regional differences in the gastrointestinal tract, (3) advanced formulations and (4) food-drug interactions. The differences of oral absorption in pediatric and geriatric populations, the specific issues in colonic absorption, the formulation approaches for poorly water-soluble (small molecules) and poorly permeable (peptides, RNA etc.) drugs, as well as the vast realm of food effects, are some of the topics discussed in detail. The identified controversies and gaps in the current understanding of gastrointestinal absorption-related processes are used to create a roadmap for the future of oral drug absorption research.
- 650 _2
- $a aplikace orální $7 D000284
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a počítačová simulace $7 D003198
- 650 _2
- $a příprava léků $7 D004339
- 650 _2
- $a interakce mezi potravou a léky $7 D018565
- 650 _2
- $a gastrointestinální trakt $x metabolismus $7 D041981
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a intestinální absorpce $7 D007408
- 650 _2
- $a léčivé přípravky $x chemie $x metabolismus $7 D004364
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Abrahamsson, Bertil $u Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden
- 700 1_
- $a Artursson, Per $u Department of Pharmacy, Uppsala University, Uppsala, Sweden
- 700 1_
- $a Batchelor, Hannah $u Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
- 700 1_
- $a Berben, Philippe $u Pharmaceutical Development, UCB Pharma SA, Braine- l'Alleud, Belgium
- 700 1_
- $a Bernkop-Schnürch, Andreas $u Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria
- 700 1_
- $a Butler, James $u GlaxoSmithKline Research and Development, Ware, United Kingdom
- 700 1_
- $a Ceulemans, Jens $u Janssen Pharmaceutica NV, Beerse, Belgium
- 700 1_
- $a Davies, Nigel $u Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden
- 700 1_
- $a Dupont, Didier $u INRAE, Institut Agro, STLO, Rennes, France
- 700 1_
- $a Flaten, Gøril Eide $u Department of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway
- 700 1_
- $a Fotaki, Nikoletta $u Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom
- 700 1_
- $a Griffin, Brendan T $u School of Pharmacy, University College Cork, Cork, Ireland
- 700 1_
- $a Jannin, Vincent $u Lonza Pharma & Biotech, Colmar, France
- 700 1_
- $a Keemink, Janneke $u Janssen Pharmaceutica NV, Beerse, Belgium
- 700 1_
- $a Kesisoglou, Filippos $u Pharmaceutical Sciences, Merck & Co. Inc., Rahway, NJ, USA
- 700 1_
- $a Koziolek, Mirko $u Abbvie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
- 700 1_
- $a Kuentz, Martin $u Institute for Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, Basel, Switzerland
- 700 1_
- $a Mackie, Alan $u School of Food Science & Nutrition, University of Leeds, Leeds, United Kingdom
- 700 1_
- $a Meléndez-Martínez, Antonio J $u Food Colour & Quality Laboratory, Area of Nutrition & Food Science, Universidad de Sevilla, Seville, Spain
- 700 1_
- $a McAllister, Mark $u Drug Product Design, Pfizer PGRD, Sandwich, United Kingdom
- 700 1_
- $a Müllertz, Anette $u Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark
- 700 1_
- $a O'Driscoll, Caitriona M $u School of Pharmacy, University College Cork, Cork, Ireland
- 700 1_
- $a Parrott, Neil $u F. Hoffmann-La Roche Ltd, Basel, Switzerland
- 700 1_
- $a Paszkowska, Jadwiga $u Physiolution Polska Sp. Z o.o., Wroclaw, Poland
- 700 1_
- $a Pavek, Petr $u Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Porter, Christopher J H $u Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia
- 700 1_
- $a Reppas, Christos $u Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a Stillhart, Cordula $u F. Hoffmann-La Roche Ltd, Basel, Switzerland
- 700 1_
- $a Sugano, Kiyohiko $u College of Pharmaceutical Sciences, Ritsumeikan University, Shiga, Japan
- 700 1_
- $a Toader, Elena $u Faculty of Medicine, University of Medicine and Pharmacy of Iasi, Romania
- 700 1_
- $a Valentová, Kateřina $u Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Vertzoni, Maria $u Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a De Wildt, Saskia N $u Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, the Netherlands
- 700 1_
- $a Wilson, Clive G $u Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
- 700 1_
- $a Augustijns, Patrick $u Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. Electronic address: patrick.augustijns@kuleuven.be
- 773 0_
- $w MED00006623 $t Advanced drug delivery reviews $x 1872-8294 $g Roč. 171, č. - (2021), s. 289-331
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33610694 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145215 $b ABA008
- 999 __
- $a ok $b bmc $g 1751819 $s 1155621
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 171 $c - $d 289-331 $e 20210218 $i 1872-8294 $m Advanced drug delivery reviews $n Adv Drug Deliv Rev $x MED00006623
- LZP __
- $a Pubmed-20220113
